Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, Hattori A, Tsuchida J, Higuchi T, Nishimukai A, Murase K, Takatsuka Y, Kihara T, Ling Y, Okuda S, Hirota S, Miyoshi Y. Nagahashi M, et al. Among authors: oshiro a. Breast Cancer. 2025 Jan 14. doi: 10.1007/s12282-025-01665-y. Online ahead of print. Breast Cancer. 2025. PMID: 39808396
Health and Well-being of Family ('Ohana) Caregivers of Native Hawaiian and Pacific Islander Adults Living with Alzheimer's Disease and Related Dementias.
Jackson AM, Muller CJ, Okamoto SK, Weaver RH, Kim SM, Haakenstad M, Pfeaster C, Cachola Z, Oshiro A, Ideue K, Schoenberg N, Sinclair K. Jackson AM, et al. Among authors: oshiro a. J Transcult Nurs. 2024 Sep 30:10436596241286232. doi: 10.1177/10436596241286232. Online ahead of print. J Transcult Nurs. 2024. PMID: 39350494
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
Mitsuyoshi A, Nagahashi M, Kanaoka H, Oshiro A, Togashi Y, Hattori A, Tsuchida J, Higuchi T, Nishimukai A, Murase K, Takatsuka Y, Miyoshi Y. Mitsuyoshi A, et al. Among authors: oshiro a. Int J Clin Oncol. 2024 Dec;29(12):1850-1859. doi: 10.1007/s10147-024-02625-w. Epub 2024 Sep 15. Int J Clin Oncol. 2024. PMID: 39278979
One-year choroidal thickness changes after photodynamic therapy for central serous chorioretinopathy evaluated by widefield optical coherence tomography.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Miyara Y, Oshiro A, Maehira M, Yamauchi Y, Koizumi H. Sawaguchi S, et al. Among authors: oshiro a. Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3805-3814. doi: 10.1007/s00417-024-06578-8. Epub 2024 Jul 12. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38995353
92 results